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Abstract
Metallo-β-lactamases (MBLs) hydrolyze almost all classes of β-lactam antibiotic, including
carbapenems—currently first choice drugs for opportunistic infections by Gram-negative
bacterial pathogens. MBL inhibitor development is complicated by the diversity within this
group of enzymes, and by the appearance of new enzymes that continue to be identified
both as chromosomal genes and on mobile genetic elements. One such newly discovered
MBL is DIM-1, a mobile enzyme originally discovered in the opportunist pathogen Pseudo-
monas stutzeri but subsequently identified in other species and locations. DIM-1 is a sub-
class B1 MBL more closely related to the TMB-1, GIM-1 and IMP enzymes than to other
clinically encountered MBLs such as VIM and NDM; and possesses Arg, rather than the
more usual Lys, at position 224 in the putative substrate binding site. Here we report the
crystallization and structure determination of DIM-1. DIM-1 possesses a binuclear metal
center with a 5 (rather than the more usual 4) co-ordinate tri-histidine (Zn1) site and both 4-
and 5-co-ordinate Cys-His-Asp- (Zn2) sites observed in the two molecules of the crystallo-
graphic asymmetric unit. These data indicate a degree of variability in metal co-ordination
geometry in the DIM-1 active site, as well as facilitating inclusion of DIM-1 in structure-
based MBL inhibitor discovery programmes.
Introduction
Acquired metallo-β-lactamases (MBLs) present a global public health challenge [1]. Their high
hydrolytic activity against carbapenems, (broad-spectrum β-lactams of ultimate choice for
Gram-negative infections), and their non-susceptibility to serine β-lactamase inhibitors, make
their dissemination significant in the rise of antibiotic resistant pathogens. Sequence data define
three MBL subclasses (B1 –B3 [2]) with B1 including almost all enzymes whose genes are found
on mobile genetic elements, and thus capable of rapid dissemination across geographic and spe-
cies boundaries. B1 MBLs from the IMP, VIM and NDM groups have already been found in
PLOSONE | DOI:10.1371/journal.pone.0140059 October 9, 2015 1 / 15
OPEN ACCESS
Citation: Booth MPS, Kosmopoulou M, Poirel L,
Nordmann P, Spencer J (2015) Crystal Structure of
DIM-1, an Acquired Subclass B1 Metallo-β-
Lactamase from Pseudomonas stutzeri. PLoS ONE
10(10): e0140059. doi:10.1371/journal.pone.0140059
Editor: Anna Roujeinikova, Monash University,
AUSTRALIA
Received: April 22, 2015
Accepted: September 20, 2015
Published: October 9, 2015
Copyright: © 2015 Booth et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Crystal structures (co-
ordinates and structure factors) have been deposited
in the Protein Data Bank (www.rcsb.org/pdb) with
accession codes 4WD6 and 4ZEJ.
Funding: This study was supported by the British
Society for Antimicrobial Chemotherapy (www.bsac.
org; grant no. GA820 to J.S.), the U.K. Medical
Research Council (www.mrc.ac.uk; grant no.
G1100135 to J.S.), and the U.S. National Institutes of
Allergy and Infectious Disease (http://www.niaid.nih.
gov/; grant no. 1R01AI100560-01 to J.S.). The
funders had no role in study design, data collection
multiple hosts, both Enterobacteriaceae [3] and non-fermenters (Pseudomonas aeruginosa, Aci-
netobacter baumannii [4–6]), while additional mobile enzymes [7–9] continue to be identified.
DIM-1 (Dutch IMipenemase) was identified in a carbapenem non-susceptible isolate of the
occasional opportunist pathogen Pseudomonas stutzeri, recovered from a patient undergoing
surgery for tibial osteomyelitis [10]. The carbapenemase gene, blaDIM-1 (GenBank:
GU323019.1), resided on a class 1 integron on a 70 kb plasmid, suggesting a capability for dis-
semination, and has subsequently been identified in isolates of multiple species (Escherichia
coli, Enterobacter cloacae, Comomonas testosteroni) of African origin and in a single strain of P.
stutzeri from India [11, 12]. Independent acquisition events from a currently unknown envi-
ronmental reservoir have been suggested to account for these apparently unconnected identifi-
cations in widely separated locations [11]. The blaDIM-1 gene encodes a subclass B1 MBL
resembling TMB-1 (67% identity [7]) GIM-1 (54% identity [13]) and IMP-1 (48% identity
[14]; percentage identities are for the mature, processed polypeptides), but more distantly
related to VIM-1 and NDM-1. An alignment of selected B1 MBLs is presented in Fig 1.
Like other B1 MBLs, DIM-1 is a broad-spectrum enzyme, hydrolyzing penicillins, cephalo-
sporins and carbapenems, although compared to some enzymes turnover of some penicillins is
reduced and activity is weaker against cephalosporins, e.g. ceftazidime or cefepime, with bulky,
charged, 3’ substituents [10]. In common with GIM-1 and TMB-1, DIM-1 is distinguished
from other B1 enzymes by possession of arginine at position 224, rather than the lysine
(Lys224) found in enzymes such as the IMP and NDM groups. Recent crystal structures [16,
17] show NDM-1 Lys224 to make electrostatic interactions with the C3 carboxylate of hydro-
lyzed carbapenems, suggesting that this substitution might affect substrate binding. Here we
report the crystal structure of DIM-1, facilitating its inclusion in structure-based inhibitor dis-
covery programmes.
Materials and Methods
Protein Expression
DIM-1 was purified from E. coli TOP10 containing the plasmid pXD-1 [10] by ion-exchange
and size exclusion chromatography in a modification of previously published procedures.
Briefly, 2 L of Luria-Bertani broth were inoculated with 10 mL / L of an overnight culture and
grown for 24 h at 37°C with shaking at 160 rpm. Cells were harvested by centrifugation (4 000
g, 20 min, 4°C), washed in phosphate-buffered saline (PBS) and frozen until required. Thawed
pellets were resuspended in 25 mL / L Buffer A (50 mM Tris-Cl pH 7.5) containing protease
inhibitors (Complete EDTA-free, Roche Life Science, Burgess Hill, U.K.) and lysed by sonica-
tion. The lysate was clarified by centrifugation (15,000 g, 30 min, 4°C) and dialyzed overnight
(4°C) against 1 L buffer A. The dialysate was loaded onto a 50 mL Q-sepharose column (Sigma,
Poole, U.K.) which was washed in buffer A until absorbance returned to baseline. Bound pro-
tein was eluted in buffer A using a 300 mL 0–0.5 M NaCl gradient; DIM-1 eluted at approxi-
mately 0.1 M NaCl as identified by hydrolysis of the chromogenic cephalosporin nitrocefin
[18]. DIM-1 containing fractions were concentrated by centrifugal ultrafiltration, loaded onto
a 300 mL Superdex-75 column pre-equilibrated in Buffer B (50 mM Tris-Cl 200 mMNaCl pH
7.5) and eluted in the same buffer. The purity of the final preparation was greater than 95% as
adjudged by SDS—PAGE [19]. The purified protein was concentrated for crystallization trials
by centrifugal ultrafiltration.
Crystallization and Structure Solution
Sparse matrix crystallization screening with the Morpheus suite [20] used a Pheonix robot
(Art-Robbins) to set sitting drops (0.5 μL each of DIM-1 (15 mg / mL) and reservoir solution)
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in 96-well plates with 100 μL well volume. Crystals appeared after 5–10 days’ incubation
(20°C) in 20% polyethylene glycol (PEG) 550 monomethyl ether (MME) / 10% PEG 20 000; 50
mMHEPES / 50 mMMOPS pH 7.5; were mounted in rayon loops, snap-frozen and stored in
liquid nitrogen until required. For soaking experiments, ceftazidime (Sigma, Poole, U.K.) dis-
solved to 250 mM in dimethyl sulfoxide (DMSO) was added to the drop to a final concentra-
tion of 85 mM and 33% DMSO and crystals frozen after 1 hour incubation at 20°C. Diffraction
data were collected on an ADSC Quantum 4 detector mounted on beamline I03 of Diamond
Light Source (Didcot, U.K.) and reflections integrated, scaled and merged using HKL2000 [21].
Phases were obtained by molecular replacement using PHASER [22] with IMP-1 (PDB acces-
sion 1DDK; [23]) as a search model. The model was built using Coot [24] and refined using
Refmac5 [25] as implemented in the CCP4 software suite [26] with TLS (Translation/Libra-
tion/Screw) groups identified by the TLSMD server [27, 28]. The quality of the final model was
assessed using PROCHECK [29] and Molprobity [30]. Data collection and refinement statistics
Fig 1. Alignment of DIM-1with Selected SubclassB1Metallo-β-Lactamases. Invariant residues are
highlighted on a red background; conservative substitutions are colored red. Residue numbers according to the
Class B β-Lactamase (BBL) standard numbering scheme are positioned above the sequences; individual
residues discussed in the text are numbered below the sequences. This Figure was prepared using ESPript [15].
doi:10.1371/journal.pone.0140059.g001
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are given in Table 1. Co-ordinates and structure factors have been deposited with the Protein
Data Bak (www.rcsb.org) with accession codes 4WD6 (native structure) and 4ZEJ (ceftazi-
dime-exposed structure).
Results and Discussion
DIM-1 crystallized in space group P 21 21 21 with crystals containing two molecules in the
asymmetric unit (Table 1). The structure was solved by molecular replacement and could be
built as two polypeptide chains. Two complete data sets were collected, a native data set from a
crystal diffracting to 2.2 Å resolution (dataset 1) and a second, higher resolution data set (data-
set 2) arising from one of a number of crystals that had been soaked with the cephalosporin cef-
tazidime in DMSO, but for which no electron density corresponding to a bound β-lactam
could be resolved. As this crystal diffracted to higher resolution (1.8 Å) and yielded higher
quality data (Table 1) this structure was also solved and refined. Non-crystallographic symme-
try was not employed at any stage in the refinement process; therefore our data provide struc-
tures for four independently refined DIM-1 monomers. The final models contain 219 (residues
Table 1. Data Collection and Refinement Statistics.
Dataset Dataset 1 Dataset 2
Processing HKL2000 [21] HKL2000
Beamline DLS I03 DLS I03
Space Group P 21 21 21 P 21 21 21
Cell Dimensions (Å) a = 47.72 b = 47.86
c = 185.22
a = 46.40 b = 46.98
c = 183.76
Wavelength (Å) 0.9763 0.9763
Resolution (Å) 50.00–2.20 (2.28–2.20)a 50.00–1.80 (1.86–1.80)a
Total reﬂections 149 531 496 348
Unique reﬂections 21 133 (1 504)a 38 481 (3 667)a
Completeness (%) 94.5 (68.4)a 99.6 (96.6)a
Redundancy 7.1 (5.9)a 12.9 (7.0)a
I / (sig. I) 32.5 (6.6)a 29.6 (2.5)a
Rmerge (%) 5.1 (25.1)
a 8.8 (50.1)a
Reﬁnement REFMAC5 REFMAC5
Total reﬂections 20 006 (1 016)a 36 522 (2 499)a
Resolution (Å) 42.55–2.20 (2.26–2.20)a 91.88–1.79 (1.84–1.79)a
Rcryst (%) 20.7 (23.9)
a 17.2 (21.7)a
Rfree (%)
b 27.4 (34.2)a 18.9 (22.8)a
RMS bond length (Å) 0.0138 0.0078
RMS bond angle (Å) 1.6167 1.2289
Protein atoms 3 392 3 434
Water molecules 126 192
% residues in Ramachandran regions (favored/
allowed/disallowed)
95.3/4.2/0.5 97.2/2.3/0.5
B-factors (protein)c 47.38 (55.26) 30.98 (39.81)
B-factors (water molecules) 48.57 38.68
PDB accession code 4WD6 4ZEJ
a Data for the highest resolution shell are in parentheses.
b Rfree was calculated with 5% of the reﬂections omitted.
cFigures in parentheses are for chain B.
doi:10.1371/journal.pone.0140059.t001
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39–294 according to the standard class B β-lactamase (BBL) numbering scheme [2]) amino
acids per chain, apart from chain B of the lower resolution structure (dataset 1) for which weak
electron density meant that residues 25–28 (60–64; BBL residue numberings are given in
parentheses throughout this paper) inclusive were not modelled. Overall Cα rms deviations
between the four chains were a maximum 0.36 Å. For the four chains (A and B of dataset 1 and
A and B of dataset 2, respectively) 95/ 94/ 97/ 97% of residues lie within the most favored
regions of the Ramachandran plot and a further 4/ 6/ 2/ 2% within the additionally allowed
regions [30]. In three of the four chains Asp-48 (84) lies in the disfavored Ramachandran
region due to its involvement in a buried hydrogen bond network, involving Ser-33 (69), Asn-
34 (70), Thr-76 (115), Arg-82 (121) and Gly-199 (262) that is common to most members of
the B1 MBL subfamily and connects the two halves of the protein beneath the active site [31].
DIM-1 adopts the αβ/βα sandwich fold of the MBL hydrolase superfamily, with the active
site situated in the groove between the two domains and containing two zinc ions (Fig 2A).
Superposition (using SSMsuperpose [32]) with other available B1 MBL structures (Fig 2B)
indicates that DIM-1 most closely resembles GIM-1 (Cα rmsd 0.87 Å) and IMP-1 (Cα rmsd
0.91 Å). Among B1 enzymes the MBL fold is well conserved, with significant differences appar-
ent at the N-terminus, in the length of the C-terminal α-helix, and in the flexible loop L3 (resi-
dues 25–32 (60–68)) that connects the β2 and β3 strands. Crystallographic [23, 33–35],
mutagenic and kinetic [36, 37], NMR [38, 39] and molecular dynamics [40] evidence indicates
that this loop adjusts its conformation on β-lactam or inhibitor binding and contributes to sub-
strate affinity and specificity. In the lower resolution (dataset 1) DIM-1 structure the L3 loop
could not be modelled for chain B, but in chain A it extends over the active site groove in a
“closed” conformation more typical of MBL complexes [17, 34, 35, 41] than of other uncom-
plexed B1 MBL structures. These differences may arise from differences in crystal contacts-
while the apex of loop L3 of chain A lies close both to chain B and symmetry related molecules,
fewer contacts are made by the equivalent subunit of chain B. In the higher resolution structure
obtained from dataset 2, the complete loop L3 could be modeled for both chains, but chain B
featured elevated B-factors consistent with a reduced involvement in crystal contacts. Estab-
lishing whether the observed conformation of the DIM-1 L3 loop arises primarily from crystal
contacts, or indeed reflects that adopted on substrate and/or inhibitor binding, must await
determination of structures for the relevant complexes.
Fig 2. Crystal Structure of DIM-1. A. Overall fold of the enzyme. Protein backbone is color-ramped from
blue (N-) to red (C-terminus). Active site residues are rendered as sticks (carbon atoms in green, other atom
colors as standard). Zinc ions (gray) and water molecules (red) are shown as spheres. B. Superposition of B1
MBL structures: DIM-1 (green); BcII (pdb accession 1BC2 ([43], blue); IMP-1 (1DDK [23], teal); VIM-2 (1KO3
[44], magenta); BlaB (1M2X [45], dark green); CcrA (1ZNB [46], yellow); NDM-1 (3Q6X [41], cyan); IND-7
(3L6N [47], red) and GIM-1 (2YNT [48], orange). This Figure was generated using Pymol (www.pymol.org).
doi:10.1371/journal.pone.0140059.g002
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Our structure also confirms that DIM-1 features hydrophobic aliphatic amino acids (valine)
at positions 25 (61) and 31 (67) at the base of the L3 loop, and an aromatic residue (phenylala-
nine) at position 28 (64) at its apex. In this DIM-1 resembles IMP-1 (and similar enzymes such
as GIM-1 [13] or KHM-1 [9]) rather than the VIM enzymes (where positions 25 (61) and 31
(67) are occupied by aromatic residues) or NDM-1 (where the L3 loop contains proline at posi-
tion 26 (62) and adopts a different conformation; Fig 3). As discussed above, inhibitor binding
to enzymes such as CcrA [33] or BcII [39] can involve conformational changes in the L3 loop,
and be affected by mutations within it [36]. Moreover, comparisons of inhibition of multiple
B1 enzymes that differ in their L3 loops (including NDM, IMP and VIM, but not DIM,
enzymes) by a series of hydroxythiazole compounds identified differences between enzymes of
up to two orders of magnitude in IC50 values [42]. Unfortunately, limited structural data are
available that permit direct comparison of inhibitor binding to different MBL targets. However,
structures for complexes of the thiol L-captopril with IMP-1 (pdb id 4C1F), NDM-1 (pdb
4EXS [17]) and VIM-2 (pdb 4C1D) show that this adopts different conformations that are in
part imposed by the proximity of different residues on the L3 loop (residues Met-61 of NDM-
1; Val-61 of IMP-1 and Phe-62 and Tyr-67 of VIM-2) to the captopril pyrrolidine ring. Com-
parison of these structures with that of DIM-1 (Fig 4) suggests that positioning of Phe-28(64)
on loop L3 over the active site, together with the presence of Val-25 (61), Val-31 (67) and Trp-
51(87) would support an orientation for the binding of the captopril pyrrolidine to DIM-1 that
is similar to that adopted upon binding to IMP-1, and that differs from those observed with
VIM-2 or NDM-1. It will be of interest to establish the extent to which this similarity between
the L3 loops of IMP-1 and DIM-1 results in similar inhibition profiles, and similar modes of
inhibitor binding.
Loop L10 (residues 160–176 (223–239)) on the opposite side of the active site groove also
shows features that distinguish DIM-1 from related enzymes. The DIM-1 L10 loop lacks Trp-
Fig 3. L3 Loop Conformations in Subclass B1 Metallo-β-Lactamases. A. DIM-1 (green); B. IMP-1 (1DDK
[23], teal); C. VIM-2 (1KO3 [44], magenta); D. NDM-1 (3Q6X [41], cyan). This Figure was generated using
Pymol.
doi:10.1371/journal.pone.0140059.g003
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165 (228), which in GIM-1 restricts this part of the active site cavity [48] and instead has serine
at this position. Like GIM-1, DIM-1 possesses tyrosine, rather than the more usual asparagine,
at position 170 (233), which further constrains the active site groove and provides a hydropho-
bic surface for substrate interactions, but abolishes the possible electrostatic contacts between
substrate and the Asn-170 (233) side chain that have been proposed for some other B1
enzymes ([17, 35, 49]. The DIM-1 active site also features a close electrostatic contact between
the side chains of Glu-78 (119) and Lys-111 (165), forming a bridge across the active site
groove in the vicinity of the probable binding site for substituent groups at the R1 position of
the β-lactam core (i.e. the C6/C7 substituents of penicillins or cephalosporins, respectively).
Taken together, these factors create an active site in DIM-1 that is narrower and more defined
than the relatively wide open groove of many other B1 MBLs (Fig 5).
Electron density maps (Fig 6A) unequivocally identify two metal ions in the DIM-1 active
site, consistent with the binuclear species being the physiological form of B1 MBLs [51, 52]. As
no particular precautions were taken to avoid oxidation of the ligand Cys-158 (221), which is
associated with loss of the metal ion in the Zn2 site in certain B1 MBLs, we surmise that this
occurs less readily in DIM-1 than in some other enzymes such as BcII, SPM-1 or VIM-2 [31,
45]. All active site metal ions were refined as zinc, with occupancies of 1.0. This procedure
yielded B-factors for the individual zinc ions of 42.58 and 48.04 Å2 (chain A Zn1 and Zn2
respectively, dataset 1); 50.73 and 57.25 Å2 (chain B Zn1 and Zn2 respectively, dataset 1); 23.43
and 26.41 Å2 (chain A Zn1 and Zn2 respectively, dataset 2); and 27.13 and 36.58 Å2 (chain B
Zn1 and Zn2 respectively, dataset 2). This compares with B-factors for the complete individual
protein chains of 47.38 and 55.26 Å2 (chains A and B; dataset 1) and 30.98 and 39.81 Å2 (chains
A and B; dataset 2). The consistency between the B-values obtained for the modelled zinc ions
and the respective protein chains suggests that refining the bound metal ions as zinc is reason-
able. However, while we consider zinc to be the most likely metal ion to be present in the DIM-
Fig 4. Comparison of DIM-1 Active Site with L-Captopril-bound Complexes of Subclass B1Metallo-β-
Lactamases. A. DIM-1 (green); B. IMP-1 (4C1F, teal); C. VIM-2 (4C1D, magenta); D. NDM-1 (4EXS [17],
cyan). This Figure was generated using Pymol.
doi:10.1371/journal.pone.0140059.g004
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1 active site, the available data cannot preclude the possibility that some fraction of other
metallated species may be present.
In the four independently refined DIM-1 chains the two metal ions lie approximately 4.00
Å–4.40 Å apart (distances in Table 2) and are liganded by the conserved residues His-77 (116),
His-79 (118) and His-139 (196) (tri-histidine or Zn1 site); and Asp-81 (120), Cys-158 (221)
and His-200 (263); Cys-His-Asp or Zn2 site). A “bridging” water molecule (or hydroxide ion)
that is generally proposed to be the nucleophile in the hydrolytic reaction [53], is positioned
between the two metal ions (Fig 6A, Wat1), lying closer to Zn1 that Zn2. (Zinc:ligand distances
are given in Table 2). (In chain A of the higher resolution structure (dataset 2) this “bridging”
ligand was modelled as a chloride ion (chloride was present in the buffer used for size exclusion
chromatography)). These features are largely typical of available crystal structures for binuclear
B1 MBLs.
B1 MBLs of known structure show a variety of co-ordination geometries at both the Zn1
and Zn2 sites. In the majority of structures the Zn1 site is tetrahedral [46, 48, 54]. However, in
three of the four refined active sites DIM-1 contains a pentaco-ordinate Zn1 center with a sec-
ond water molecule (Fig 6A, Wat2) acting as an additional ligand but at a distance (~2.4–2.5 Å
from Zn1) and with elevated B-factors (where both Wat1 andWat2 are present (dataset 1)
Wat2 B-factors 44.31 Å2 and 46.13 Å2 compared to Wat1 B-factors 34.26 Å2 and 39.77 Å2 in
chains A and B, respectively) indicative of weaker binding. In the remaining molecule (chain B
of dataset 2) this water molecule is absent and the Zn1 site is clearly tetrahedral. The Zn2 site
also differs between the four molecules. In the lower resolution structure (dataset 1) this is
clearly tetrahedral (four co-ordinate) in molecule A, while in molecule B a second, “apical”
water molecule (Fig 6A, Wat3) is present, as observed in other MBL structures [43, 46, 55], to
create a pentaco-ordinate center. In the higher resolution structure solved from dataset 2 the
position of Wat3 is occupied by chloride ions in both chains, and in both cases Zn2 is five co-
ordinated (Fig 6B).
Fig 5. Active Site Grooves of B1 Metallo-β-Lactamases. Figure shows surfaces of A. DIM-1; B. GIM-1
(pdb accession 2YNT [48]) C. IMP-1 (1DDK [23]) and D. NDM-1 (3Q6X [41]) colored according to
electrostatic potential from red (- 0.5 V) to blue (+ 0.5 V). Hydrolyzed ampicillin bound to NDM-1 is shown as
sticks (carbon atoms green, other atom colors as standard). This Figure was generated using CCP4MG [50].
doi:10.1371/journal.pone.0140059.g005
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Five co-ordinate Zn1 sites have been observed in some other B1 MBL crystal structures,
notably those of IND-7 (Fig 6C, [47]) and reduced VIM-2 (Fig 6D, [44]). Notably, Yamaguchi
et al [47] used comparisons with structures of biomimetic copper complexes [56] to describe
the co-ordination geometry about IND-7 Zn1. Calculation of the structural parameter τ ((β −
α)/60), where angle α refers to His79 (118) ND1—Zn1—His139 (196) NE2 and β to O (Wat2)
—Zn1—His77 (116) NE2, can be used to represent the distortion from square to trigonal pyra-
midal co-ordination geometry. (The value of τ is considered to be 0 for an ideal square pyramid
and 1 for an ideal trigonal bipyramid). On this basis the IND-7, reduced VIM-2 and DIM-1
Zn1 sites can all be described as distorted trigonal bipyramidal, with values of τ all above 0.85.
In all three structures Wat2 is relatively distant from Zn1 compared to other ligands, consistent
with proposals [47] that this defines the position occupied by the carbonyl oxygen of incoming
β-lactams and hence may be readily displaced when substrates bind. Superposition with struc-
tures of NDM-1 complexes with hydrolysed β-lactams (e.g. 3Q6X; [41] Fig 7) indeed locates
DIM-1 Wat-2 in the approximate position of the C7 carboxylate formed on β-lactam hydroly-
sis and thus supports this assertion.
The structural parameter τ can also be used to describe the geometry of the Zn2 site. As
described above, defining angles α as (Wat1 (Cl-))—Zn2—His200 (263) NE2 and β as O (Wat3
Fig 6. DIM-1 Active Site and Comparison with Selected B1 Metallo-β-Lactamases. A. Stereogram of
DIM-1 active site (dataset 1 structure). Carbon atoms are colored green, zinc ions gray, water molecules red,
other atom colors as standard. Electron density map shown is 2|Fo|-|Fc|.ϕcalc, contoured at 1.0 σ. B. Overlay
of DIM-1 active sites for the four independently refined molecules. Structures from dataset 1 are in darker,
and dataset 2 in lighter, shades. Dashed lines showmetal:ligand interactions in chain A of dataset 1. Note
presence of additional water molecule (Wat-3; dataset 1 chain B) or chloride ions (dataset 2 structures)
bound to Zn2 ion, and bridging chloride ion in dataset 2 chain A structure. C. Active site of IND-7 (3L6N [47]).
Note five- and four-fold co-ordination of Zn1 and Zn2, respectively. D. Active site of VIM-2 (1KO3 [44]). Not
five-fold co-ordination of both Zn2+ ions. E. Active site of NDM-1 (3PSU [54]) Note four- and five-fold co-
ordination of Zn1 and Zn2, respectively. This Figure was generated using Pymol.
doi:10.1371/journal.pone.0140059.g006
Crystal Structure of DIM-1 Metallo-β-Lactamase
PLOS ONE | DOI:10.1371/journal.pone.0140059 October 9, 2015 9 / 15
(Cl-))—Zn2—Asp81 (120) OD2 gives values of τ ranging from 0.18 to 0.37 for the three chains
where Zn2 is five-co-ordinate. This indicates that the DIM-1 Zn2 site can be described as a dis-
torted square pyramid rather than the trigonal bipyramid observed in e.g. VIM-2 (Fig 6D pdb
1KO3 [44]). Under these criteria the Zn2 sites of NDM-1 (Fig 6E, pdb 3SPU [54]) and CcrA
Table 2. Metal:ligand distances (Å).
Structure Dataset 1 Dataset 2
Zn1:His77(116) 2.35a (2.19)b 2.16a (2.18)b
Zn1:His79(118) 2.05 (2.34) 2.05 (2.16)
Zn1:His139(196) 2.12 (2.32) 2.09 (2.07)
Zn1:Wat1 1.81 (1.89) 2.26c (1.99)
Zn1:Wat2 2.53 (2.40) 2.52
Zn2:Asp81(120) 2.33 (2.60) 2.03 (2.09)
Zn2:Cys168(221) 2.16 (2.11) 2.19 (2.13)
Zn2:His200(263) 2.24 (2.12) 2.15 (2.20)
Zn2:Wat1 2.44 (2.37) 2.27c (2.75)
Zn2:Wat3 (2.43) 2.47c (2.87)c
Zn1:Zn2 3.97 (4.02) 4.22 (4.39)
Wat-1:Asp81(120) 2.94 (3.24) 2.98 (3.04)
aChain A.
bFigures in parentheses are for chain B.
cReﬁned as a chloride ion
doi:10.1371/journal.pone.0140059.t002
Fig 7. Overlay of B1 Metallo-β-Lactamase Active Sites Showing Hydrolyzed β-LactamBinding.
Figure shows DIM-1, IMP-1 (1DDK [23], carbon, zinc and waters teal); VIM-2 (1KO3 [44], carbon, zinc and
waters magenta) and NDM-1:ampicillin complex (3Q6X [41], carbon, zinc and waters cyan). Interactions of
hydrolyzed ampicillin with NDM-1 are shown as dashed lines. Note differing positions of Arg-161 (224) (DIM-
1), Lys-224 (IMP-1, NDM-1) and Arg-228 (VIM-2). This Figure was generated using Pymol.
doi:10.1371/journal.pone.0140059.g007
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(pdb 1ZNB [46]) can also be described as square pyramidal. An additional contrast is provided
by the IND-7 (Fig 6C [47]) and GIM-1 [48] structures, where in both cases Zn2 is tetrahedrally
co-ordinated, as observed in one of the four DIM-1 chains described here.
The separation of the two active site metal ions in the four DIM-1 structures ranges from
3.97 Å (dataset 1 chain A) to 4.39 Å (dataset 2 chain B). While comparison with other struc-
tures is complicated by the lack of atomic resolution data (overall coordinate errors based on
R-values are 0.36 Å, dataset 1, and 0.13 Å, dataset 2), these values appear to be at the upper end
of the range observed in other B1 MBL structures, which for uncomplexed enzymes lies more
typically in the 3.5–3.7 Å range (e.g. IND-7 3.64 Å, pdb 3L6N [47]; GIM-1 3.45–3.50 Å pdbs
2YNT and 2YNW [48]) and see recent near-atomic resolution structures of BcII (3.50 Å, 1.20
Å resolution, pdb id 4C09) and VIM-2 (3.51 Å, 1.29 Å resolution, pdb id 4BZ3). Increased sep-
arations have been observed for structures determined under more acidic conditions [16, 57],
and the metal—metal distance is also observed to increase in some complexes with hydrolyzed
β-lactams (e.g. NDM-1:ampicillin pdb 3Q6X 4.58 Å [41] compared to unliganded NDM-1
3.56–3.97 Å pdb 3SPU), indicating that the MBL active site architecture is able to adapt to
accommodate bound ligands. It is notable that other structures in which, as is the case for data-
set 2, chloride ions are observed in the MBL active site (e.g. 1KO3 [44] or 2BG2 [57]) also fea-
ture relatively large separations between the two zinc ions (4.20 Å and 4.09 Å respectively).
Our observation of a variety of metal co-ordination arrangements in DIM-1, and the range of
architectures observed in the zinc sites of other enzymes, together highlight the flexibility of
co-ordination geometry about both metal ions of the B1 MBL active site (for a review see [58]).
This is also consistent with proposals that metal co-ordination geometry can change during β-
lactam binding and hydrolysis [59–61].
In common with some other mobile B1 MBLs (e.g. GIM-1 and TMB-1; [7, 13]) DIM-1 fea-
tures an arginine at residue 161 (224), rather than the lysine found at the equivalent position in
most other enzymes (e.g. NDM-1, IMP-1, SPM-1, IND-7). Structures of inhibitor and β-lactam
complexes of the IMP-1 and NDM-1 enzymes [17, 23, 41], as well as evidence from directed
mutagenesis studies [62, 63], implicate this lysine in substrate interactions via the invariant car-
boxylate at the β-lactam C3 (penicillin) or C4 (cephalosporin) position. Structural comparisons
(Fig 7) suggest that DIM-1 Arg161 (224) NH1 might make similar contacts, although we note
that, relative to Zn2 (also implicated in binding substrate carboxylate) DIM-1 Arg161 (224)
NH1 is not identically located to Lys224 NZ of e.g. IMP-1 or NDM-1. Steady-state kinetic data
[7, 10, 13] show enzymes with Arg224 to be less efficient than other B1 MBLs against some
substrates, in particular penicillins (for which kcat values are notably reduced [7]). It is possible
that interactions involving Arg224, rather than Lys224, result in binding of some substrates in
orientations that are less optimal for hydrolysis.
In summary, the DIM-1 crystal structure presented here displays similarities and differences
when compared to those for other B1 MBLs. While the overall fold and binuclear zinc center
are common to all B1 MBLs, the DIM-1 structure highlights the variability evident in the active
site architecture around the L3 and L10 loops and in the identity and location of residues
(DIM-1 Arg161 (224)) likely to be involved in binding the β-lactam C2/C3 carboxylate. More-
over, our data provide further evidence of variability in the co-ordination of both of the cata-
lytic zinc ions in B1 MBLs. Possession of a relatively plastic active site which differs
significantly between individual enzymes is one reason why MBLs remain challenging targets
for inhibitor design. The availability of structural information for enzymes, such as DIM-1,
whose active sites contain such distinguishing features and that, by virtue of their mobilization
and presence in pathogens, are a present challenge to clinical β-lactam use, is thus a stepping
stone to development of broad spectrum inhibitors effective across the full range of MBLs.
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